EVI1 mRNA expression levels in EVI1-1D⁺ and EVI1-1D⁻ AML samples in cohort A and B determined by Northern blot. Human 600-bp EVI1 probe and as control a murine GAPDH fragment were used. Patients I and II represent AML samples without EVI1 expression. The patient numbers correspond to those in Table 1.